Primary Site >> Esophagus Cancer
Gene >> LY6K
|
|
|
|---|---|---|
|
Ref: Identification of human leukocyte antigen-A24-restricted epitope peptides derived from gene products upregulated in lung and esophageal cancers as novel targets for immunotherapy. PMID: 17784873 Ref: Cancer-testis antigen lymphocyte antigen 6 complex locus K is a serologic biomarker and a therapeutic target for lung and esophageal carcinomas. PMID: 18089789 |
Ref: Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens. PMID: 22776426 |
Ref: Phase I clinical trial of vaccination with LY6K-derived peptide in patients with advanced gastric cancer. PMID: 23613128 Ref: Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients. PMID: 24708624 |